Here are 11 insights:
1. The company’s total first quarter revenue hit $61.9 million, reflecting a 9.9 percent increase year-over-year.
2. K2M’s domestic first quarter revenue totaled $46.2 million, up 9.5 percent year-over-year.
3. The company’s U.S. complex spine business grew 7.6 percent year-over-year.
4. U.S. minimally invasive surgery business grew 14.4 percent year-over-year.
5. K2M’s U.S. degenerative business saw a 9.4 percent jump year-over-year.
6. In the first quarter, international revenue hit $15.7 million, reflecting an 11.1 percent increase year-over-year.
7. K2M reported a net loss of $10.9 million for the first quarter of 2017, compared to $10.2 million in the first quarter of 2016.
7. The company’s adjusted EBITDA was $300,000 for the first quarter, compared to $1.1 million in the first quarter of 2016.
8. In February, K2M unveiled its Balance ACS platform, which leverages 3-D dimensional solutions across the continuum of care for spine surgery patients.
9. In April, K2M teamed up with LifeHealthcare Group for a distribution agreement in Australia and New Zealand.
10. Also in April, K2M received product registrations in Japan for the MESA and EVEREST lines.
11. K2M reaffirms its fiscal year 2017 guidance expectations. It expects total revenue between $263 million and $270 million.
More articles on devices:
EOI releases successful Q1 revenue report — 4 details
How single-use instruments facilitate jump from inpatient to outpatient total knee arthroplasty
Johnson & Johnson, US Defense Dept. reach $260M deal on orthopedic devices — 4 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
